Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System
Portfolio Pulse from
Milestone Scientific has received Federal Supply Schedule (FSS) approval for its CompuFlo® Epidural System, opening up significant market opportunities within federal healthcare systems.
November 26, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Milestone Scientific has obtained FSS approval for its CompuFlo® Epidural System, which is expected to open up significant market opportunities within federal healthcare systems.
The FSS approval allows Milestone Scientific to access federal healthcare markets, which could lead to increased sales and revenue. This regulatory milestone is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100